Prelude Therapeutics (PRLD) IPO Opens 33% Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St set to open lower after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
IPO for Prelude Therapeutics (PRLD) Paused on Volatility After Ramp Higher
September 25, 2020 12:06 PM EDTToday's IPO for Prelude Therapeutics (NASDAQ: PRLD) was paused on volatility after ramping higher. Shares were last up 55% after opening up 33%.
... MorePrelude Therapeutics Inc. (PRLD) Prices 8.325M Share IPO at $19/Sh
September 25, 2020 6:17 AM EDTPrelude Therapeutics Incorporated (NASDAQ: PRLD) today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share. The gross proceeds to Prelude, before deducting underwriting commissions and offering expenses, are expected to be... More



